Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-482
Closed -$83.9K 984
2025
Q4
$83.9K Buy
482
+195
+68% +$35.6K ﹤0.01% 1804
2025
Q3
$41.3K Buy
287
+150
+109% +$18.4K ﹤0.01% 1983
2025
Q2
$13.8K Buy
137
+48
+54% +$3.67K ﹤0.01% 1831
2025
Q1
$6.79K Sell
89
-50
-36% -$3.83K ﹤0.01% 1833
2024
Q4
$9.6K Sell
139
-320
-70% -$23K ﹤0.01% 1471
2024
Q3
$33.5K Sell
459
-769
-63% -$56.8K ﹤0.01% 1470
2024
Q2
$82.3K Sell
1,228
-4,206
-77% -$163K 0.01% 977
2024
Q1
$147K Buy
+5,434
New +$152K 0.03% 741

Other funds holding INSM

AlphaQuest's INSM Position: Q1 2026 in Review

AlphaQuest sold out of Insmed (INSM) in Q1 2026, closing a stake of 482 shares — an estimated $83.9K sold.

AlphaQuest first reported a position in INSM in Q1 2024 and held it in 8 quarters. The position peaked at $147K in Q1 2024. 674 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • AlphaQuest reported no remaining Insmed position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 482 Insmed shares in Q1 2026, an estimated $83.9K.
  • AlphaQuest first reported a position in Insmed in Q1 2024 and held it in 8 quarters.
  • AlphaQuest's Insmed position peaked at $147K in Q1 2024.
  • 674 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.